134 related articles for article (PubMed ID: 11084353)
1. Muscular dystrophy: the worm turns to genetic disease.
Chamberlain JS; Benian GM
Curr Biol; 2000 Nov; 10(21):R795-7. PubMed ID: 11084353
[TBL] [Abstract][Full Text] [Related]
2.
Ellwood RA; Piasecki M; Szewczyk NJ
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063069
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome changes during the initiation and progression of Duchenne muscular dystrophy in Caenorhabditis elegans.
Hrach HC; O'Brien S; Steber HS; Newbern J; Rawls A; Mangone M
Hum Mol Genet; 2020 Jun; 29(10):1607-1623. PubMed ID: 32227114
[TBL] [Abstract][Full Text] [Related]
4. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans.
Gieseler K; Grisoni K; Ségalat L
Curr Biol; 2000 Sep; 10(18):1092-7. PubMed ID: 10996789
[TBL] [Abstract][Full Text] [Related]
5. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.
Gaud A; Simon JM; Witzel T; Carre-Pierrat M; Wermuth CG; Ségalat L
Neuromuscul Disord; 2004 Jun; 14(6):365-70. PubMed ID: 15145337
[TBL] [Abstract][Full Text] [Related]
6. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18).
Towers PR; Lescure P; Baban D; Malek JA; Duarte J; Jones E; Davies KE; Ségalat L; Sattelle DB
Genomics; 2006 Nov; 88(5):642-9. PubMed ID: 16962739
[TBL] [Abstract][Full Text] [Related]
8. Shrinking genes for therapy.
Bonetta L
Nat Med; 2002 Mar; 8(3):222. PubMed ID: 11875490
[No Abstract] [Full Text] [Related]
9. Overexpression of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient Caenorhabditis elegans.
Gieseler K; Grisoni K; Mariol MC; Ségalat L
Neuromuscul Disord; 2002 May; 12(4):371-7. PubMed ID: 12062255
[TBL] [Abstract][Full Text] [Related]
10. Duchenne muscular dystrophy: stalled at the junction?
Ségalat L; Anderson JE
Eur J Hum Genet; 2005 Jan; 13(1):4-5. PubMed ID: 15483645
[No Abstract] [Full Text] [Related]
11. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process.
Brouilly N; Lecroisey C; Martin E; Pierson L; Mariol MC; Qadota H; Labouesse M; Streichenberger N; Mounier N; Gieseler K
Hum Mol Genet; 2015 Nov; 24(22):6428-45. PubMed ID: 26358775
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.
Berger J; Berger S; Hall TE; Lieschke GJ; Currie PD
Neuromuscul Disord; 2010 Dec; 20(12):826-32. PubMed ID: 20850317
[TBL] [Abstract][Full Text] [Related]
13. What do animal models have to tell us regarding Duchenne muscular dystrophy?
Wells DJ; Wells KE
Acta Myol; 2005 Dec; 24(3):172-80. PubMed ID: 16629050
[TBL] [Abstract][Full Text] [Related]
14. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript.
Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M
Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544
[TBL] [Abstract][Full Text] [Related]
15. Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.
McNally EM; Wyatt EJ
Circulation; 2017 Sep; 136(11):979-981. PubMed ID: 28893959
[No Abstract] [Full Text] [Related]
16. The worm in us - Caenorhabditis elegans as a model of human disease.
Baumeister R; Ge L
Trends Biotechnol; 2002 Apr; 20(4):147-8. PubMed ID: 11906745
[No Abstract] [Full Text] [Related]
17. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
18. [C. elegans as a model for human inherited degenerative diseases].
Ségalat L; Néri C
Med Sci (Paris); 2003 Dec; 19(12):1218-25. PubMed ID: 14691746
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
20. [Genotype-phenotype discordance in a Duchenne muscular dystrophy patient due to a novel mutation: insights into the shock absorber function of dystrophin].
López-Hernández LB; van Heusden D; Soriano-Ursúa MA; Figuera-Villanueva L; Vázquez-Cárdenas NA; Canto P; Gómez-Díaz B; Coral-Vázquez RM
Rev Neurol; 2011 Jun; 52(12):720-4. PubMed ID: 21594857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
